Literature DB >> 14688330

Role of TNF receptor-associated factor 3 in the CD40 signaling by production of reactive oxygen species through association with p40phox, a cytosolic subunit of nicotinamide adenine dinucleotide phosphate oxidase.

Yun Jung Ha1, Jong Ran Lee.   

Abstract

To extend our previous report, which showed the production of the reactive oxygen species (ROS) after the CD40 ligation in the B cells, we further examined the possible mechanisms for ROS production and the involvement of CD40-induced ROS in p38 activation. Our research shows that the stimulation of WEHI 231 B lymphomas with anti-CD40 induced ROS production and p38 activation. An antioxidant N-acetyl-L-cysteine or an inhibitor for NADPH oxidase blocked both of these, but the inhibitors for 5-lipoxygenase did not. We also show that the treatment of cells with inhibitors for the phosphatidylinositol 3-kinase (PI3-K) interfered with the CD40-induced ROS production and p38 activation. In addition, when overexpressed with a dominant negative form of either Rac1 (N17Rac1) or the TNFR-associated factor (TRAF) 3, the WEHI 231 B cells did not show a full response to the CD40 stimulation to produce ROS. Molecular association studies further revealed that the TRAF3 association with p40(phox), a cytosolic subunit of NADPH oxidase and p85 (a subunit of PI3-K), may possibly be responsible for the production of ROS by CD40 stimulation in WEHI 231 B cells. Collectively, these data suggest that the CD40-induced ROS production by NADPH oxidase in WEHI 231 requires the role of TRAF3, as well as activities of PI3-K and Rac1.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14688330     DOI: 10.4049/jimmunol.172.1.231

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  15 in total

1.  TLR activation of the transcription factor XBP1 regulates innate immune responses in macrophages.

Authors:  Fabio Martinon; Xi Chen; Ann-Hwee Lee; Laurie H Glimcher
Journal:  Nat Immunol       Date:  2010-03-28       Impact factor: 25.606

Review 2.  Roles of tumor necrosis factor receptor associated factor 3 (TRAF3) and TRAF5 in immune cell functions.

Authors:  Joanne M Hildebrand; Zuoan Yi; Claire M Buchta; Jayakumar Poovassery; Laura L Stunz; Gail A Bishop
Journal:  Immunol Rev       Date:  2011-11       Impact factor: 12.988

3.  Ligation of CD40 receptor in human B lymphocytes triggers the 5-lipoxygenase pathway to produce reactive oxygen species and activate p38 MAPK.

Authors:  Yun Jung Ha; Hee Jung Seul; Jong Ran Lee
Journal:  Exp Mol Med       Date:  2011-02-28       Impact factor: 8.718

4.  Epstein-Barr virus LMP1 modulates lipid raft microdomains and the vimentin cytoskeleton for signal transduction and transformation.

Authors:  David G Meckes; Nathan F Menaker; Nancy Raab-Traub
Journal:  J Virol       Date:  2012-11-14       Impact factor: 5.103

Review 5.  Multiple roles of TRAF3 signaling in lymphocyte function.

Authors:  Gail A Bishop; Ping Xie
Journal:  Immunol Res       Date:  2007       Impact factor: 2.829

6.  Differential role of reactive oxygen species in the activation of mitogen-activated protein kinases and Akt by key receptors on B-lymphocytes: CD40, the B cell antigen receptor, and CXCR4.

Authors:  Rosaline L Lee; Jens Westendorf; Michael R Gold
Journal:  J Cell Commun Signal       Date:  2007-05-10       Impact factor: 5.782

Review 7.  TRAF3 as a powerful and multitalented regulator of lymphocyte functions.

Authors:  Gail A Bishop
Journal:  J Leukoc Biol       Date:  2016-05-06       Impact factor: 4.962

8.  Activation of CD40 with platelet derived CD154 promotes reactive oxygen species dependent death of human hepatocytes during hypoxia and reoxygenation.

Authors:  Ricky H Bhogal; Christopher J Weston; Stuart M Curbishley; David H Adams; Simon C Afford
Journal:  PLoS One       Date:  2012-01-25       Impact factor: 3.240

9.  Components of the antigen processing and presentation pathway revealed by gene expression microarray analysis following B cell antigen receptor (BCR) stimulation.

Authors:  Jamie A Lee; Robert S Sinkovits; Dennis Mock; Eva L Rab; Jennifer Cai; Peng Yang; Brian Saunders; Robert C Hsueh; Sangdun Choi; Shankar Subramaniam; Richard H Scheuermann
Journal:  BMC Bioinformatics       Date:  2006-05-02       Impact factor: 3.169

Review 10.  Molecular basis and therapeutic implications of CD40/CD40L immune checkpoint.

Authors:  TingTing Tang; Xiang Cheng; Billy Truong; LiZhe Sun; XiaoFeng Yang; Hong Wang
Journal:  Pharmacol Ther       Date:  2020-10-20       Impact factor: 12.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.